ClinicalTrials.Veeva

Menu

Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies

S

Saint Louis University (SLU)

Status

Completed

Conditions

Kidney Transplant
Renal Transplant

Treatments

Diagnostic Test: Procurement Biopsy: Permanent section
Diagnostic Test: Procurement Biopsy: Frozen section

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this research study is to compare the impact of the availability of biopsy results at the time of organ offers on the use and outcomes of kidneys from deceased donors.

Full description

Randomization of biopsy processing will be performed at the level of the deceased donor.

If the participant agrees to be in this study and signs the informed consent, at the time that a kidney is accepted for them, the accepted deceased donor will be randomized, like a flip of a coin, to one of two groups.

  • Group 1: biopsies will be processed immediately (routine "frozen section") and results will be available to clinical teams at the time of the organ offers. Frozen section refers to a process where tissue from the biopsy sample is prepared by freezing and then slicing the tissue sample. Importantly, it can be done in about 15 to 20 minutes. Frozen sections are done when an immediate answer is needed; however, the quality of the sample is not always optimal.
  • Group 2: biopsies will be processed using "permanent sections" - these results will not be available until after the organ is transplanted. Permanent section refers to a process where tissue from the biopsy sample is prepared by placing the tissue sample in a fixative, called formalin, to preserve the tissue, processing it through other additional solutions, and then placing it in paraffin wax. After the wax hardens, the tissue is cut into very thin slices, which are placed on slides and stained. This process normally takes several days.

There is a 50/50 chance that the donor will be randomized to immediate biopsy processing by frozen section, versus permanent processing that yields results after transplant. If for any reason their surgeon feels that it would not be safe to proceed without the biopsy result, he or she will have the ability to receive the results of the biopsy before the transplant. The study team will record any episodes of this occurrence.

Enrollment

12 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Kidney transplant candidate
  • On waitlist for kidney transplant at the time of informed consent at one of the participating sites
  • Age 18 or older
  • Willing and able to provide informed consent for participation in the study

Exclusion criteria

  • Unable or unwilling to provide informed consent to participate in the study
  • Younger than 18 years old
  • Not on waitlist for kidney transplant at the time of informed consent at one of the participating centers
  • Candidates for or recipients of multi-organ transplants (kidney along with another solid organ)

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

12 participants in 2 patient groups

Procurement Biopsy: Frozen section
Active Comparator group
Description:
In the routine care condition, biopsies will be processed immediately as a frozen section.
Treatment:
Diagnostic Test: Procurement Biopsy: Frozen section
Procurement Biopsy: Permanent section
Active Comparator group
Description:
In the intervention group, the biopsy processing will be delayed to permanent section, and therefore not available until allocation is complete.
Treatment:
Diagnostic Test: Procurement Biopsy: Permanent section

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems